RIV : Canopy Rivers Inc Stock Profile

Last Updated: 3/12/2024 0:47:16

Canopy Rivers Inc trades with the ticker RIV on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and producti

Looking to invest in Canopy Rivers Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.

RIV.TO Stock Price and Key Stats

ETF Key Stats

Exchange: TSX

Market Cap : $213.652MM

PE Ratio:

Price: 12.09 (Updated: 3/12/2024 0:47:16)

Canopy Rivers Inc (RIV) vs Competitors in Drug Manufacturers – Specialty & Generic

Lets see how RIV.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:

Aleafia Health Inc, Aphria Inc, Acerus Pharmaceuticals Corporation, Correvio Pharma Corp, The Supreme Cannabis Company, Inc


Drug Manufacturers – Specialty & Generic Industry Comparisons

Company Market Cap ($MM) P/E Ratio EV/EBITDA Dividend Yield
Aleafia Health Inc (ALEF) $189.563 N/A 0.0 0.0%
Aphria Inc (APHA) $4,439.753 N/A 598.009 0.0%
Acerus Pharmaceuticals Corporation (ASP) $2.775 N/A -2.796 0.0%
Correvio Pharma Corp (CORV) $37.067 N/A 0.0 0.0%
The Supreme Cannabis Company, Inc (FIRE) $255.583 N/A 0.0 0.0%

EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield  

Comparisons within Drug Manufacturers – Specialty & Generic

  • Canopy Rivers Inc (RIV) vs Aleafia Health Inc (ALEF)
    • ALEF has higher EPS (-0.274 vs -0.923). ALEF provides dividends, while RIV does not. ALEF and RIV both have P/E’s under 0.
  • Canopy Rivers Inc (RIV) vs Aphria Inc (APHA)
    • APHA has higher EPS (0.116 vs -0.923). APHA provides dividends, while RIV does not. APHA and RIV both have P/E’s under 0.
  • Canopy Rivers Inc (RIV) vs Acerus Pharmaceuticals Corporation (ASP)
    • RIV has higher EPS (-0.923 vs -4.41). ASP provides dividends, while RIV does not. ASP and RIV both have P/E’s under 0.
  • Canopy Rivers Inc (RIV) vs Correvio Pharma Corp (CORV)
    • CORV has higher EPS (-0.879 vs -0.923). CORV provides dividends, while RIV does not. CORV and RIV both have P/E’s under 0.
  • Canopy Rivers Inc (RIV) vs The Supreme Cannabis Company, Inc (FIRE)
    • FIRE has higher EPS (-0.052 vs -0.923). FIRE provides dividends, while RIV does not. FIRE and RIV both have P/E’s under 0.

Our Recommendation: Review
May not stand out on key metrics or lacks sufficient data for a strong recommendation.

How to Buy RIV stock on the TSX

You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:

ImageProduct TitleFeaturesPrice
Editor's Choice
Wealthsimple Trade

Wealthsimple Trade

  • ETF buys and sells have $0 trading fees
  • Desktop and mobile trading
  • Reputable Brand
  • Beautiful Design
Get $25 Signup Bonus
Reliable Pick


  • ETF buys have $0 trading fees
  • Desktop and mobile trading
  • Most types of accounts available
Get $50 Free Stock Trades
Photo of author
Author Bio - Qayyum Rajan is a CFA Charterholder with 10+ years of finance experience and the co-creator of Wealthawesome.com. He has previously worked as a portfolio manager at RBC Dominion Securities and other roles at asset managers like Sentry Investments. He then started building websites and fintech apps to bring finance to everyone.

Check Out These Posts:

Leave a Comment